Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations.
Hermans C, Altisent C, Batorova A, Chambost H, De Moerloose P, Karafoulidou A, Klamroth R, Richards M, White B, Dolan G; European Haemophilia Therapy Standardisation Board. Hermans C, et al. Among authors: klamroth r. Haemophilia. 2009 May;15(3):639-58. doi: 10.1111/j.1365-2516.2008.01950.x. Haemophilia. 2009. PMID: 19444969 Review.
Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report.
Astermark J, Altisent C, Batorova A, Diniz MJ, Gringeri A, Holme PA, Karafoulidou A, Lopez-Fernández MF, Reipert BM, Rocino A, Schiavoni M, von Depka M, Windyga J, Fijnvandraat K; European Haemophilia Therapy Standardisation Board. Astermark J, et al. Haemophilia. 2010 Sep 1;16(5):747-66. doi: 10.1111/j.1365-2516.2010.02231.x. Epub 2010 Apr 14. Haemophilia. 2010. PMID: 20398077 Review.
The international factor IX treatment network survey.
Berntorp E, Shapiro AD, Waters J, Astermark J; International Factor IX Treatment Network. Berntorp E, et al. Haemophilia. 2012 May;18(3):e60-2. doi: 10.1111/j.1365-2516.2012.02767.x. Epub 2012 Mar 8. Haemophilia. 2012. PMID: 22404549 No abstract available.
Future needs for continuing innovation in hemophilia: improving outcomes for individuals of all severities, including women and those in resource-constrained regions.
Blatný J, Astermark J, Catarino C, Dolan G, Fijnvandraat K, Hermans C, Holstein K, Jiménez-Yuste V, Klamroth R, Lavin M, Lenting PJ, Lobet S, Mancuso ME, Motwani J, O'Donnell JS, Königs C. Blatný J, et al. Among authors: klamroth r. Ther Adv Hematol. 2024 Sep 30;15:20406207241285143. doi: 10.1177/20406207241285143. eCollection 2024. Ther Adv Hematol. 2024. PMID: 39381602 Free PMC article. Review.
The association between unemployment and treatment among adults with hemophilia.
Qvigstad C, Sørensen LQ, Tjønnfjord GE, Holme PA; Age-related DeVelopments ANd ComorbiditiEs in hemophilia Working Group. Qvigstad C, et al. Res Pract Thromb Haemost. 2024 Jul 14;8(5):102514. doi: 10.1016/j.rpth.2024.102514. eCollection 2024 Jul. Res Pract Thromb Haemost. 2024. PMID: 39188890 Free PMC article.
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B.
Cuker A, Kavakli K, Frenzel L, Wang JD, Astermark J, Cerqueira MH, Iorio A, Katsarou-Fasouli O, Klamroth R, Shapiro AD, Hermans C, Ishiguro A, Leavitt AD, Oldenburg JB, Ozelo MC, Teitel J, Biondo F, Fang A, Fuiman J, McKay J, Sun P, Rasko JEJ, Rupon J; BENEGENE-2 Trial Investigators. Cuker A, et al. Among authors: klamroth r. N Engl J Med. 2024 Sep 26;391(12):1108-1118. doi: 10.1056/NEJMoa2302982. N Engl J Med. 2024. PMID: 39321362 Clinical Trial.
197 results